Literature DB >> 8000564

In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3.

C A Altar1, J A Siuciak, P Wright, N Y Ip, R M Lindsay, S J Wiegand.   

Abstract

The TrkB and TrkC receptor tyrosine kinases have been identified as high-affinity receptors for the neurotrophic factors brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5) and NT-3 respectively. These receptor classes were identified and mapped by the in situ hybridization of antisense riboprobes complementary to portions of the intracellular (tyrosine kinase) or extracellular (ligand-binding) domains of trkB and trkC mRNA, and by the distribution of high-affinity [125I]BDNF, [125I]NT-4/5 and [125I]NT-3 binding sites in adjacent rat brain sections. Both methods showed that TrkB and TrkC receptors are abundant and widely expressed throughout the brain. Kinase or extracellular domain trkC probes labelled neuronal somata in a qualitatively similar manner in virtually every major area of the forebrain. Neither trkC probe labelled non-neuronal cells except for elements within cerebral arteries and arterioles. The kinase domain trkB probe hybridized exclusively to neurons. Neurons expressing trkB were even more widely distributed than those expressing trkC. The extracellular domain trkB probe labelled neurons with the same relative distribution as the trkB kinase domain probe, but also hybridized extensively with non-neural cells, particularly astrocytes, ependyma and choroid epithelium cells. The distribution of [125I]NT-3 binding sites generally resembled that of trkC hybridization, particularly in the neocortex, striatum and thalamus. [125I]BDNF and [125I]NT-4/5 binding sites were more widely distributed and denser than those for [125I]NT-3, and resembled the trkB hybridization pattern. These patterns are consistent with the preferential binding in the brain of TrkC receptors by [125I]NT-3 and of TrkB receptors by [125I]BDNF and [125I]NT-4/5. That the predominantly neuronal patterns of hybridization obtained with kinase and extracellular domain probes for trkC are qualitatively indistinguishable suggests that truncated and full-length forms of TrkC are expressed within extensively overlapping populations of neurons. In marked contrast to TrkC, expression of the full-length and truncated forms of TrkB appears to be largely segregated, being expressed principally on neurons and non-neuronal cells respectively. The abundant and widespread neuronal distribution of full-length, signal-transducing forms of TrkB and TrkC predict that their cognate ligands, BDNF, NT-4/5 and NT-3, may exert direct effects on a large proportion of neurons within the mature brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000564     DOI: 10.1111/j.1460-9568.1994.tb01001.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  26 in total

1.  Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.

Authors:  Babak Baseri; James J Choi; Thomas Deffieux; Gesthimani Samiotaki; Yao-Sheng Tung; Oluyemi Olumolade; Scott A Small; Barclay Morrison; Elisa E Konofagou
Journal:  Phys Med Biol       Date:  2012-03-09       Impact factor: 3.609

2.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.

Authors:  K D Anderson; N Panayotatos; T L Corcoran; R M Lindsay; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Postsynaptic BDNF signalling regulates long-term potentiation at thalamo-amygdala afferents.

Authors:  S Meis; T Endres; V Lessmann
Journal:  J Physiol       Date:  2011-11-14       Impact factor: 5.182

4.  The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB.

Authors:  B Xu; W Gottschalk; A Chow; R I Wilson; E Schnell; K Zang; D Wang; R A Nicoll; B Lu; L F Reichardt
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

5.  Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice.

Authors:  Kelly E Bosse; Francis K Maina; Johnna A Birbeck; Marion M France; Joseph J P Roberts; Michelle L Colombo; Tiffany A Mathews
Journal:  J Neurochem       Date:  2011-12-02       Impact factor: 5.372

6.  Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.

Authors:  J Diaz; C Pilon; B Le Foll; C Gros; A Triller; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward.

Authors:  Danielle L Graham; Vaishnav Krishnan; Erin B Larson; Ami Graham; Scott Edwards; Ryan K Bachtell; Diana Simmons; Lana M Gent; Olivier Berton; Carlos A Bolanos; Ralph J DiLeone; Luis F Parada; Eric J Nestler; David W Self
Journal:  Biol Psychiatry       Date:  2008-11-06       Impact factor: 13.382

8.  Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons.

Authors:  Yuriko Iwakura; Hiroyuki Nawa; Ichiro Sora; Moses V Chao
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

9.  Effects of trkB knockout on topography and ocular segregation of uncrossed retinal projections.

Authors:  Jennifer Rodger; Douglas O Frost
Journal:  Exp Brain Res       Date:  2009-03-13       Impact factor: 1.972

10.  Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.

Authors:  R Chavez-Valdez; L J Martin; S Razdan; E B Gauda; F J Northington
Journal:  Neuroscience       Date:  2013-12-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.